Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Studies from St. Vincent's Hospital, Department of Orthopaedics have provided new data on cancer gene therapy
March 25th, 2008
Data detailed in 'DNAzyme technology and cancer therapy: cleave and let die' have been presented. "Novel molecules are constantly being discovered and developed to find better means of managing debilitating and fatal diseases, which include cancer in its multiple forms. Among these molecules, and as a direct consequence of a better understanding of the molecular basis of diseases, are those falling within the class of gene therapeutics," investigators in Fitzroy, Australia report. "Among these players, deoxyribozymes (DNAzymes) have come a long way from being just another analytic tool available to molecular biologists. Recent studies have shown the potential DNAzymes...
Source: Cancer Weekly (2008-03-25)
|
